Shenzhen Kangtai Biological Products Co Ltd Sustainability Reports
The company focuses on the research, development, production, and sale of human vaccines. It specializes in biopharmaceutical innovations including polyvalent, genetic engineering, and inactivated vaccine varieties.
Sector: Manufacturing
Country: China
Exchange: Shenzhen Stock Exchange
ISIN: CNE100002Q33
7 reports from 2018 to 2024
- Shenzhen Kangtai Biological Products Co Ltd 2024 Annual Report
- Shenzhen Kangtai Biological Products Co Ltd 2024 Environmental, Social and Governance (ESG) Report
- Shenzhen Kangtai Biological Products Co Ltd 2021 Social Responsibility and ESG Report
- Shenzhen Kangtai Biological Products Co Ltd 2021 Corporate Social Responsibility Report and ESG Report
- Shenzhen Kangtai Biological Products Co Ltd 2020 Social Responsibility Report